164 related articles for article (PubMed ID: 18450430)
1. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.
Bares M; Brunovsky M; Kopecek M; Novak T; Stopkova P; Kozeny J; Sos P; Krajca V; Höschl C
Eur Psychiatry; 2008 Aug; 23(5):350-5. PubMed ID: 18450430
[TBL] [Abstract][Full Text] [Related]
2. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
[TBL] [Abstract][Full Text] [Related]
3. The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study.
Bares M; Novak T; Brunovsky M; Kopecek M; Stopkova P; Krajca V; Höschl C
J Psychiatr Res; 2012 Feb; 46(2):219-25. PubMed ID: 21937059
[TBL] [Abstract][Full Text] [Related]
4. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
Bares M; Brunovsky M; Kopecek M; Stopkova P; Novak T; Kozeny J; Höschl C
J Psychiatr Res; 2007; 41(3-4):319-25. PubMed ID: 16889798
[TBL] [Abstract][Full Text] [Related]
5. Using prefrontal and midline right frontal EEG-derived theta cordance and depressive symptoms to predict the differential response or remission to antidepressant treatment in major depressive disorder.
de la Salle S; Jaworska N; Blier P; Smith D; Knott V
Psychiatry Res Neuroimaging; 2020 Aug; 302():111109. PubMed ID: 32480044
[TBL] [Abstract][Full Text] [Related]
6. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments.
Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Krajca V; Höschl C
Eur Neuropsychopharmacol; 2010 Jul; 20(7):459-66. PubMed ID: 20421161
[TBL] [Abstract][Full Text] [Related]
7. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.
Hunter AM; Leuchter AF; Morgan ML; Cook IA
Am J Psychiatry; 2006 Aug; 163(8):1426-32. PubMed ID: 16877657
[TBL] [Abstract][Full Text] [Related]
8. Early change of prefrontal theta cordance and occipital alpha asymmetry in the prediction of responses to antidepressants.
Bares M; Novak T; Vlcek P; Hejzlar M; Brunovsky M
Int J Psychophysiol; 2019 Sep; 143():1-8. PubMed ID: 31195067
[TBL] [Abstract][Full Text] [Related]
9. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.
Hunter AM; Nghiem TX; Cook IA; Krantz DE; Minzenberg MJ; Leuchter AF
Clin EEG Neurosci; 2018 Sep; 49(5):306-315. PubMed ID: 29224411
[TBL] [Abstract][Full Text] [Related]
10. Cordance derived from REM sleep EEG as a biomarker for treatment response in depression--a naturalistic study after antidepressant medication.
Adamczyk M; Gazea M; Wollweber B; Holsboer F; Dresler M; Steiger A; Pawlowski M
J Psychiatr Res; 2015 Apr; 63():97-104. PubMed ID: 25772006
[TBL] [Abstract][Full Text] [Related]
11. Early changes in prefrontal activity characterize clinical responders to antidepressants.
Cook IA; Leuchter AF; Morgan M; Witte E; Stubbeman WF; Abrams M; Rosenberg S; Uijtdehaage SH
Neuropsychopharmacology; 2002 Jul; 27(1):120-31. PubMed ID: 12062912
[TBL] [Abstract][Full Text] [Related]
12. Changes in brain function of depressed subjects during treatment with placebo.
Leuchter AF; Cook IA; Witte EA; Morgan M; Abrams M
Am J Psychiatry; 2002 Jan; 159(1):122-9. PubMed ID: 11772700
[TBL] [Abstract][Full Text] [Related]
13. QEEG changes during switch from depression to hypomania/mania: a case report.
Kopecek M; Tislerova B; Sos P; Bares M; Novak T; Krajca V; Brunovsky M
Neuro Endocrinol Lett; 2008 Jun; 29(3):295-302. PubMed ID: 18580843
[TBL] [Abstract][Full Text] [Related]
14. Prefrontal changes and treatment response prediction in depression.
Cook IA; Leuchter AF
Semin Clin Neuropsychiatry; 2001 Apr; 6(2):113-20. PubMed ID: 11296311
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data.
Bares M; Novak T; Kopecek M; Brunovsky M; Stopkova P; Höschl C
Eur Arch Psychiatry Clin Neurosci; 2015 Feb; 265(1):73-82. PubMed ID: 24848366
[TBL] [Abstract][Full Text] [Related]
16. In patients suffering from major depressive disorders, quantitative EEG showed favorable changes in left and right prefrontal cortex.
Haghighi M; Ludyga S; Rahimi B; Jahangard L; Ahmadpanah M; Torabian S; Esnaashari F; Nazaribadie M; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
Psychiatry Res; 2017 May; 251():137-141. PubMed ID: 28199912
[TBL] [Abstract][Full Text] [Related]
17. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
18. Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression.
Hunter AM; Ravikumar S; Cook IA; Leuchter AF
Acta Psychiatr Scand; 2009 Apr; 119(4):266-73. PubMed ID: 19077131
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.
Hunter AM; Muthén BO; Cook IA; Leuchter AF
J Psychiatr Res; 2010 Jan; 44(2):90-8. PubMed ID: 19631948
[TBL] [Abstract][Full Text] [Related]
20. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
